Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis.
暂无分享,去创建一个
Li-Xuan Qin | Samuel Singer | L. Qin | S. Singer | Penelope L Decarolis | R. O'connor | C. Angeles | N. Moraco | S. Ugras | Christina V Angeles | Ryan M Gobble | Elliott R Brill | Stacy Ugras | Rachael B O'Connor | Nicole H Moraco | Cristina Antonescu | R. Gobble | C. Antonescu | E. Brill | R. O'Connor | Nicole H. Moraco
[1] Li-Xuan Qin,et al. Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] I. Shnitsar,et al. PTK7 recruits dsh to regulate neural crest migration , 2008, Development.
[3] C. Sander,et al. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. , 2007, Cancer research.
[4] Kylie L. Gorringe,et al. Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization , 2005, Genes, chromosomes & cancer.
[5] O. Myklebost,et al. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential , 2007, BMC Genomics.
[6] Douglas B. Evans,et al. Single-Nucleotide Polymorphisms of DNA Damage Response Genes Are Associated with Overall Survival in Patients with Pancreatic Cancer , 2008, Clinical Cancer Research.
[7] M. Miller,et al. Lemon encodes an unusual receptor protein-tyrosine kinase expressed during gametogenesis in Hydra. , 2000, Developmental biology.
[8] Paul M. Schneider,et al. High-Throughput Analysis of Genome-Wide Receptor Tyrosine Kinase Expression in Human Cancers Identifies Potential Novel Drug Targets , 2004, Clinical Cancer Research.
[9] 大堀 理,et al. Memorial Sloan-Kettering Cancer Center , 2020, Definitions.
[10] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .
[11] L. Layfield,et al. Translocations and amplifications of chromosome 12 in liposarcoma demonstrated by the LSI CHOP breakapart rearrangement probe. , 2009, Archives of pathology & laboratory medicine.
[12] G. Giaccone,et al. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] M. Miyazaki,et al. Upregulation of topoisomerase IIα expression in advanced gallbladder carcinoma: a potential chemotherapeutic target , 2008, Journal of Cancer Research and Clinical Oncology.
[14] S. Lundgren,et al. pleural mesothelioma : Genome-wide expression patterns reflecting eneral resistance mechanisms and a proposal of novel targets luf , 2009 .
[15] Ximing J. Yang,et al. Topoisomerase IIα in Wilms’ tumour: gene alterations and immunoexpression , 2006, Journal of Clinical Pathology.
[16] Samuel Singer,et al. Histologic Subtype and Margin of Resection Predict Pattern of Recurrence and Survival for Retroperitoneal Liposarcoma , 2003, Annals of surgery.
[17] J. Rosen,et al. Chk1 is haploinsufficient for multiple functions critical to tumor suppression. , 2004, Cancer cell.
[18] M. Kattan,et al. Subtype Specific Prognostic Nomogram for Patients With Primary Liposarcoma of the Retroperitoneum, Extremity, or Trunk , 2006, Annals of surgery.
[19] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[20] M. Gonen,et al. Concordance probability and discriminatory power in proportional hazards regression , 2005 .
[21] J. Gimble,et al. Yield of human adipose-derived adult stem cells from liposuction aspirates. , 2004, Cytotherapy.
[22] M. Kattan,et al. Postoperative nomogram for 12-year sarcoma-specific death. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] A. Ullrich,et al. Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family. , 1995, Oncogene.
[24] P. Terrier,et al. Pleomorphic Liposarcoma: Clinicopathologic, Immunohistochemical, and Follow-up Analysis of 63 Cases: A Study From the French Federation of Cancer Centers Sarcoma Group , 2002, The American journal of surgical pathology.
[25] S. Thibodeau,et al. Mutations in the ataxia telangiectasia and rad3‐related–checkpoint kinase 1 DNA damage response axis in colon cancers , 2007, Genes, chromosomes & cancer.
[26] Z. Hall. Cancer , 1906, The Hospital.
[27] Dejan Juric,et al. Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] G. Rosen,et al. The Impact of Chemotherapy on the Survival of Patients With High-grade Primary Extremity Liposarcoma , 2004, Annals of surgery.
[29] Hala Gali-Muhtasib,et al. Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. , 2008, Cancer research.
[30] J. Nitiss. Targeting DNA topoisomerase II in cancer chemotherapy , 2009, Nature Reviews Cancer.
[31] Jihwan Song,et al. Cloning and characterization of the full-length mouse Ptk7 cDNA encoding a defective receptor protein tyrosine kinase. , 2004, Gene.
[32] W. Park,et al. Chk1 frameshift mutation in sporadic and hereditary non-polyposis colorectal cancers with microsatellite instability. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[33] A. Karameris,et al. Evaluation of Topoisomerase IIa Expression in Pancreatic Ductal Adenocarcinoma: A Pilot Study Using Chromogenic in situ Hybridization and Immunohistochemistry on Tissue Microarrays , 2007, Pancreatology.
[34] R. Lothe,et al. Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] Jae-Won Jung,et al. Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis. , 2008, Biochemical and biophysical research communications.
[36] J. Edmonson,et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] C. Fisher,et al. Significant clinical benefit of first‐line palliative chemotherapy in advanced soft‐tissue sarcoma , 2008, Cancer.
[38] A. Mccarthy. Development , 1996, Current Opinion in Neurobiology.
[39] R. Tibshirani,et al. Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data , 2004, PLoS biology.
[40] J. O’Sullivan,et al. Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis. , 2009, Cancer letters.
[41] Kathleen Marchal,et al. The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor /progesterone receptor /HER-2 breast carcinomas. , 2007, Cancer research.
[42] F. Mitelman,et al. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. , 1996, The American journal of pathology.
[43] Michael A. Choti,et al. A Phosphatase Associated with Metastasis of Colorectal Cancer , 2001, Science.
[44] Nathalie Wong,et al. TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance , 2009, International journal of cancer.